FDA inspection
Eli Lilly and Company: FDA inspection ending Sep 11, 2025
FDA inspection 1282100 · Voluntary Action Indicated (VAI) · Pleasant Prairie, WI
Key facts
| Inspection ID | 1282100 |
|---|---|
| Firm | Eli Lilly and Company |
| FEI number | 3031961517 |
| Address | 10300 128th Ave |
| City | Pleasant Prairie |
| State | WI |
| ZIP | 53158-7336 |
| Fiscal year | 2025 |
| Inspection end date | Sep 11, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data